Uncategorized

Marked for destruction

Published

1 week ago

on

Nature Biotechnology, Published online: 04 June 2026; doi:10.1038/s41587-026-03182-5

The significance of the first FDA-approved PROTAC lies not in proving that targeted protein degradation is superior to conventional therapies, but in proving that degrading proteins is possible as a therapeutic.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version